ADINA vs. High Flow Nasal Cannula Comparison Study

NCT ID: NCT03171129

Last Updated: 2026-01-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-07-31

Study Completion Date

2027-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to evaluate the feasibility of using a pressure limited nasal cannula system instead of a high flow nasal cannula system in the management of premature babies with respiratory distress.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

NCPAP has been used increasingly to manage respiratory distress in newborns as well as apnea of prematurity. Humidified high flow nasal cannula devices (flows 1-8 lpm) have also been used in neonatal intensive care units.

This study is to evaluate the feasibility of using a pressure limited nasal cannula system instead of a high flow nasal cannula system in the management of premature babies with respiratory distress.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Distress Neonatal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High flow nasal cannula system w/ ADINA

The intervention is the insertion of the the ADINA device into the high flow nasal cannula system. ADINA will be placed according to weight class recommendations to increase the positive end expiratory pressure (PEEP). ADINA is actually a combination of the Neotech RAM Cannula and a clear Regulator/Pop off valve.

Group Type EXPERIMENTAL

Adaptive Dynamic Inspiratory Nasal Apparatus

Intervention Type DEVICE

Oxygen will be administered via ADINA

high flow nasal cannula system

High flow nasal cannula will deliver oxygen at 2-4 lpm of flow. High flow cannula are used to provide the control interface.

Group Type ACTIVE_COMPARATOR

High flow Nasal Canula

Intervention Type DEVICE

Oxygen will be administered via nasal canula

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Adaptive Dynamic Inspiratory Nasal Apparatus

Oxygen will be administered via ADINA

Intervention Type DEVICE

High flow Nasal Canula

Oxygen will be administered via nasal canula

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ADINA

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Neonates admitted to NICU
* Weights of 400-500 grams
* Requiring oxygen greater than 30%
* No evidence of focal lobar consolidation in lung fields

Exclusion Criteria

* Intolerance to procedure
* gelatinous skin
* known allergy to adhesive material
* interference with therapy
* profound sepsis
* pneumonia
* unmanaged apnea/bradycardia
* known or suspect complex congenital heart disease
* severe cleft lip or palate
* suspect or proven lethal congenital anomaly
* intolerance to the interface used in the devices
* inability to secure an appropriate fit of the patient nasal interface
* considered non-viable or of uncertain viability
* parental refusal.
Minimum Eligible Age

23 Weeks

Maximum Eligible Age

40 Weeks

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Loma Linda University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mitchell R Goldstein, MD

Role: PRINCIPAL_INVESTIGATOR

Loma Linda University Health

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Loma Linda University Medical Center

Loma Linda, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Tina Ramirez

Role: CONTACT

909-558-5828

Alyssa Taber

Role: CONTACT

909-558-6087

References

Explore related publications, articles, or registry entries linked to this study.

Sreenan C, Lemke RP, Hudson-Mason A, Osiovich H. High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure. Pediatrics. 2001 May;107(5):1081-3. doi: 10.1542/peds.107.5.1081.

Reference Type BACKGROUND
PMID: 11331690 (View on PubMed)

Centers for Disease Control and Prevention (CDC). Update: Ralstonia species associated with Vapotherm oxygen delivery devices--United States, 2005. MMWR Morb Mortal Wkly Rep. 2005 Nov 4;54(43):1104-5.

Reference Type BACKGROUND
PMID: 16267498 (View on PubMed)

Centers for Disease Control and Prevention (CDC). Ralstonia associated with Vapotherm oxygen delivery device--United States, 2005. MMWR Morb Mortal Wkly Rep. 2005 Oct 21;54(41):1052-3.

Reference Type BACKGROUND
PMID: 16237377 (View on PubMed)

Gregory GA, Kitterman JA, Phibbs RH, Tooley WH, Hamilton WK. Treatment of the idiopathic respiratory-distress syndrome with continuous positive airway pressure. N Engl J Med. 1971 Jun 17;284(24):1333-40. doi: 10.1056/NEJM197106172842401. No abstract available.

Reference Type BACKGROUND
PMID: 4930602 (View on PubMed)

Dutta S. High-flow nasal cannula versus nasal continuous positive airway pressure in the management of apnea of prematurity. Pediatrics. 2002 Apr;109(4):718-9; author reply 718-9. doi: 10.1542/peds.109.4.718. No abstract available.

Reference Type BACKGROUND
PMID: 11927724 (View on PubMed)

Campbell DM, Shah PS, Shah V, Kelly EN. Nasal continuous positive airway pressure from high flow cannula versus Infant Flow for Preterm infants. J Perinatol. 2006 Sep;26(9):546-9. doi: 10.1038/sj.jp.7211561. Epub 2006 Jul 13.

Reference Type BACKGROUND
PMID: 16837929 (View on PubMed)

Kubicka ZJ, Limauro J, Darnall RA. Heated, humidified high-flow nasal cannula therapy: yet another way to deliver continuous positive airway pressure? Pediatrics. 2008 Jan;121(1):82-8. doi: 10.1542/peds.2007-0957.

Reference Type BACKGROUND
PMID: 18166560 (View on PubMed)

Woodhead DD, Lambert DK, Clark JM, Christensen RD. Comparing two methods of delivering high-flow gas therapy by nasal cannula following endotracheal extubation: a prospective, randomized, masked, crossover trial. J Perinatol. 2006 Aug;26(8):481-5. doi: 10.1038/sj.jp.7211543. Epub 2006 May 25.

Reference Type BACKGROUND
PMID: 16724119 (View on PubMed)

Shoemaker MT, Pierce MR, Yoder BA, DiGeronimo RJ. High flow nasal cannula versus nasal CPAP for neonatal respiratory disease: a retrospective study. J Perinatol. 2007 Feb;27(2):85-91. doi: 10.1038/sj.jp.7211647.

Reference Type BACKGROUND
PMID: 17262040 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5160055

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

High Flow Nasal Cannula Rates in Pediatric Asthma
NCT06379607 ENROLLING_BY_INVITATION NA
Use of NAVA in Intubated Preterm
NCT00536445 WITHDRAWN PHASE1/PHASE2